Clinical Trial Update: Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps [Phase 3]

View source ↗

Summary

Phase 3 study evaluating celecoxib to prevent colorectal cancer after polyp removal has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Cancer, Rectal Cancer | Phase 3 | Status: COMPLETED